James Kihara, PRINCIPAL ACCOUNTING OFFICER at ACADIA PHARMACEUTICALS INC (ACAD), sold 1,954 shares at $21.47 ($42K) on 2026-03-25, disclosed to the SEC on 2026-03-26.
Scheduled sale ($42k) by PRINCIPAL ACCOUNTING OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.47 | 833 | $18K | 42.4% |
| 2 | $21.65 | 1,097 | $24K | 56.3% |
| 3 | $21.73 | 12 | $261 | 0.6% |
| 4 | $21.73 | 12 | $261 | 0.6% |
| Total | $21.57 avg | 1,954 | $42K | 100% |
| Filing → |
| ACAD | SELL | 2026-05-05 | $29K | — | Filing → |
| ACAD | SELL | 2026-04-07 | $23K | — | Filing → |
| ACAD | SELL | 2025-11-19 | $193K | — | Filing → |